abcarta

HealthcareSeries ASuzhou, Chinaabcarta.com

Latest round

Series A

Last raised

Nov 2019

Total raised

Undisclosed

Investors

4

About abcarta

Founded in 2018 and based in Suzhou, China, abcarta operates as a medical company that focuses on the research and development of intelligent pathology solutions. It was recognized as the National High-tech Enterprise. The company has R&D and production centers, as well as medical information and artificial intelligence centers in Suzhou and San Diego, the United States. The company mainly provides intelligent pathology solutions for pathologists, scientific research institutions, and new drug development partners. Products include PathAb antibodies, 100-channel kits, FAIP-30 automatic immunohistochemistry staining instrument, remote pathology diagnosis platform, etc. The company generates revenue by providing intelligent pathology products and services.

Who invested in abcarta

4 investors across 2 rounds

See all investors in abcarta

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 25, 2019

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Dec 10, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about abcarta

Who invested in abcarta?

abcarta has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has abcarta raised?

abcarta has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did abcarta last raise money?

abcarta's most recent round on record is a Series A, in Nov 2019.

What does abcarta do?

Founded in 2018 and based in Suzhou, China, abcarta operates as a medical company that focuses on the research and development of intelligent pathology solutions.

Where is abcarta headquartered?

abcarta is headquartered in Suzhou, China.

Which VCs invest in companies like abcarta?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at abcarta's stage. Their profiles are linked below.

Raising like abcarta? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.